136 related articles for article (PubMed ID: 37967583)
1. The effects of bivalent human papillomavirus (HPV) vaccination on high-risk anogenital HPV infection among sexually active female adolescents with and without perinatally acquired HIV.
Ounchanum P; Ounchanum P; Achalapong J; Achalapong J; Teeraananchai S; Teeraananchai S; Gatechompol S; Gatechompol S; Phongsamart W; Phongsamart W; Chokephaibulkit K; Chokephaibulkit K; Tran DNH; Tran DNH; Dang HLD; Dang HLD; Teeratakulpisarn N; Teeratakulpisarn N; Chalermchockcharoenkit A; Chalermchockcharoenkit A; Singtoroj T; Singtoroj T; Sohn AH; Sohn AH; Phanuphak N; Phanuphak N
Sex Health; 2024 Feb; 21(1):NULL. PubMed ID: 37967583
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Persistence of High-risk Anogenital Human Papillomavirus Infection Among Female Youth With and Without Perinatally Acquired Human Immunodefiency Virus Infection: A 3-year Observational Cohort Study.
Phanuphak N; Teeraananchai S; Hansudewechakul R; Gatechompol S; Chokephaibulkit K; Dang HLD; Tran DNH; Achalapong J; Teeratakulpisarn N; Chalermchockcharoenkit A; Thamkhantho M; Pankam T; Singtoroj T; Termrungruanglert W; Chaithongwongwatthana S; Kerr SJ; Sohn AH
Clin Infect Dis; 2020 Nov; 71(8):e270-e280. PubMed ID: 31768522
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Persistence, and Factors Associated With HPV Infection Among Male Adolescents With and Without Perinatally Acquired HIV Infection.
Gatechompol S; Teeratakulpisarn N; Wittawatmongkol O; Teeraananchai S; Kerr SJ; Chalermchockcharoenkit A; Thamkhantho M; Singtoroj T; Phanuphak N; Sohn AH; Chokephaibulkit K;
J Acquir Immune Defic Syndr; 2020 Dec; 85(5):553-560. PubMed ID: 32925357
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth.
Sohn AH; Kerr SJ; Hansudewechakul R; Gatechompol S; Chokephaibulkit K; Dang HLD; Tran DNH; Achalapong J; Teeratakulpisarn N; Chalermchockcharoenkit A; Thamkhantho M; Pankam T; Singtoroj T; Termrungruanglert W; Chaithongwongwatthana S; Phanuphak N;
Clin Infect Dis; 2018 Aug; 67(4):606-613. PubMed ID: 29617952
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of High-risk Nonavalent Vaccine-type Human Papillomavirus Infection Among Unvaccinated, Sexually Active Asian Female Adolescents With and Without Perinatally Acquired HIV Infection.
Sricharoenchai S; Kerr SJ; Gatechompol S; Hansudewechakul R; Dang HLD; Tran DNH; Teeratakulpisarn N; Chalermchockcharoenkit A; Achalapong J; Teeraananchai S; Singtoroj T; Phanuphak N; Sohn AH; Chokephaibulkit K;
Pediatr Infect Dis J; 2020 Jul; 39(7):615-619. PubMed ID: 32282527
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated with Morbidity and Mortality Among Sexually Active Asian Adolescents and Young Adults with Perinatally Acquired HIV.
Singtoroj T; Teeraananchai S; Chokephaibulkit K; Phanuphak N; Gatechompol S; Hansudewechakul R; Dang HLD; Tran DNH; Kerr S; Sohn AH;
AIDS Res Hum Retroviruses; 2023 Jun; 39(6):285-293. PubMed ID: 36515173
[TBL] [Abstract][Full Text] [Related]
7. Increased Burden of Concordant and Sequential Anogenital Human Papillomavirus Infections Among Asian Young Adult Women With Perinatally Acquired HIV Compared With HIV-Negative Peers.
Sohn AH; Chalermchockcharoenkit A; Teeraananchai S; Hansudewechakul R; Gatechompol S; Chokephaibulkit K; Dang HLD; Tran DNH; Achalapong J; Teeratakulpisarn N; Thamkhantho M; Phanuphak N; Ananworanich J; Reiss P; Kerr SJ
Sex Transm Dis; 2021 Mar; 48(3):200-205. PubMed ID: 32976361
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.
Moscicki AB; Karalius B; Tassiopoulos K; Yao TJ; Jacobson DL; Patel K; Purswani M; Seage GR;
Clin Infect Dis; 2019 Sep; 69(7):1183-1191. PubMed ID: 30927547
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus infections in nonsexually active perinatally HIV infected children.
Moscicki AB; Puga A; Farhat S; Ma Y
AIDS Patient Care STDS; 2014 Feb; 28(2):66-70. PubMed ID: 24460009
[TBL] [Abstract][Full Text] [Related]
10. Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.
Diakite I; Nguyen S; Sabale U; Pavelyev A; Saxena K; Tajik AA; Wang W; Palmer C
J Med Econ; 2023; 26(1):1085-1098. PubMed ID: 37608730
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study.
Chikandiwa A; Chimoyi L; Pisa PT; Chersich MF; Muller EE; Michelow P; Mayaud P; Delany-Moretlwe S
BMC Public Health; 2017 Jul; 17(Suppl 3):425. PubMed ID: 28832285
[TBL] [Abstract][Full Text] [Related]
13. Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance.
King EM; Gilson R; Beddows S; Soldan K; Panwar K; Young C; Jit M; Edmunds WJ; Sonnenberg P
Sex Transm Infect; 2015 Jun; 91(4):284-6. PubMed ID: 25887283
[TBL] [Abstract][Full Text] [Related]
14. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
Kumakech E; Andersson S; Wabinga H; Musubika C; Kirimunda S; Berggren V
BMC Womens Health; 2017 Jun; 17(1):40. PubMed ID: 28576143
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.
Mavundza EJ; Wiyeh AB; Mahasha PW; Halle-Ekane G; Wiysonge CS
Hum Vaccin Immunother; 2020; 16(2):426-435. PubMed ID: 31448991
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2 and 3 Vaccinations With the Bivalent Human Papillomavirus (HPV) Vaccine on the Prevalence and Load of HPV in Clearing and Persistent Infections in Young Women.
van Eer K; Middeldorp M; Dzebisasjvili T; Lamkaraf N; de Melker HE; Steenbergen RDM; King AJ
J Infect Dis; 2023 Oct; 228(8):1012-1022. PubMed ID: 36988110
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of vaccine-preventable anal human papillomavirus infections is associated with HIV infection among gay, bisexual, and men who have sex with men in Nairobi, Kenya.
Oo MM; Moore S; Gibbons S; Adhiambo W; Muthoga P; Siele N; Akolo M; Gebrebrhan H; Sivro A; Ball BT; Lorway RR; Severini A; Kimani J; McKinnon LR
Cancer Med; 2023 Jun; 12(12):13745-13757. PubMed ID: 37140209
[TBL] [Abstract][Full Text] [Related]
19. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Anal High-Risk Human Papillomavirus Infections Among HIV-Positive and HIV-Negative Men Who Have Sex With Men in Nigeria.
Nowak RG; Gravitt PE; He X; Ketende S; Dauda W; Omuh H; Blattner WA; Charurat ME;
Sex Transm Dis; 2016 Apr; 43(4):243-8. PubMed ID: 26967301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
